Natera

Incyte

United Therapeutics

Gilead Sciences

Insmed

Neurocrine Biosciences

Vertex Pharmaceuticals

Alnylam Pharmaceuticals

AbbVie

Sarepta Therapeutics

Direxion Daily S&P Biotech Bull 3X Shares

LABU provides daily 3 times exposure to the S&P Biotechnology Select Industry Index.

Direxion Daily Real Estate Bear 3x Shares

Direxion Daily Emerging Markets Bull 3X Shares

The S&P 500 continues to climb higher this summer (up over 16% for the year), offering opportunities that traders can capitalize on when looking at specific sectors and outside domestic equities.

3 Trades to Consider Amid Early Summer Rally

LABU is a 3X leveraged fund that has disappointed the biotech bulls. The sector looks beaten and perhaps cheap relative to long-term prospects. LABU can work for medium term returns if two requirements are met.

LABU: 2 Requirements For Making Money In This Leveraged Biotech Fund

MicroSectors U.S. Big Banks Index -3X Inverse Leveraged ETN

MicroSectors Gold Miners 3X Leveraged ETN

ProShares UltraShort Bloomberg Natural Gas

AdvisorShares MSOS 2x Daily ETF

MicroSectors U.S. Big Oil Index -3X Inverse Leveraged ETNs

MicroSectors Oil & Gas Exploration & Production -3X Inverse Leveraged ETN

Advisorshares Poseidon Dynamic Cannabis ETF

ProShares UltraShort Bloomberg Crude Oil

MicroSectors Energy -3X Inverse Leveraged ETN

Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Top Performing Leveraged/Inverse ETFs: 05/07/2023

Direxion Daily S&P 500 High Beta Bear 3X Shares

Direxion Daily Homebuilders & Supplies Bull 3X Shares

Direxion Daily Semiconductor Bear 3x Shares

Direxion Daily Dow Jones Internet Bear 3X Shares

The month of April was marked by huge volatility. Though recession fears continued to weigh on investors sentiment, cooling inflation and better-than-expected earnings drove the stocks higher.

5 Leveraged/Inverse ETFs That Gained Double Digits in April

Direxion Daily S&P Biotech Bear 3X Shares

SPDR® S&P Biotech ETF, the Biotechnology Select Industry Index ETF, has an extreme short interest of 51.16%. XBI is in an uptrend since May-June 2022. Direxion Daily S&P Biotech Bull 3X Shares ETF, the 3X leveraged Biotech ETF, is rated as a HOLD.

Leveraged Biotech ETFs: Hold LABU, Sell LABD

Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. This ETF attempts to mimic 3X the one-day performance of the SPDR S&P 500 Biotech ETF (NYSE: XBI).

Want Diversified Upside in Biotechnology? Check out LABU

Biotech stocks have pulled back and offer better risk to reward for investors, Direxion Daily S&P Biotech Bull 3x Shares ETF is a popular way to trade them. M&A is likely to drive prices for mid-cap and small-cap biopharma.

LABU: Leveraged Biotech ETF Review

iShares MSCI Emerging Markets ETF

iShares China Large-Cap ETF

iShares iBoxx High Yield Corporate Bond ETF

Invesco QQQ

Direxion Daily Semiconductor Bull 3x Shares

SPDR S&P 500 ETF Trust

ProShares UltraPro Short QQQ

ProShares UltraPro QQQ

ProShares Ultra VIX Short-Term Futures ETF

Financial Select Sector SPDR Fund

Thee ETF industry is seeing explosive growth, piling up huge assets amid the stock market turmoil. This has resulted in enough liquidity, with most of the ETFs trading at extremely higher volumes.

10 Most-Heavily Traded ETFs of Fourth-Quarter 2022

Direxion Daily CSI China Internet Index Bull 2X Shares

Direxion Daily Electric & Autonomous Vehicles Bull 2X Shares

BMO REX MicroSectors FANG+ Index 3X Leveraged ETN

ETFMG 2X Daily Alternative Harvest ETF

ProShares Ultra FTSE China 50

Direxion Daily FTSE China Bull 3X Shares

Top Performing Leveraged/Inverse ETFs: 12/04/2022

LABU is more volatile than unleveraged funds, due to its 3-times investments in the derivatives of stocks listed in its benchmark index. During the past 4 months, biotechnology stocks performed quite well, and this bull run has come during a period when the overall market performed poorly.

LABU: Opportunities For Gains Exist If Bought And Sold At Correct Price

ProShares Short S&P500

The ETF industry is seeing explosive growth, piling up huge assets amid the stock market turmoil. This has resulted in enough liquidity in the ETF world, with most ETFs trading at extremely higher volumes.

10 Most-Heavily Traded ETFs of Third Quarter 2022

Direxion Daily Cloud Computing Bull 2X Shares

Direxion Daily S&P 500 High Beta Bull 3X Shares

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Direxion Daily Retail Bull 3X Shares

ProShares Ultra Nasdaq Cloud Computing ETF

Direxion Daily Consumer Discretionary Bull 3X Shares

Direxion Daily Dow Jones Internet Bull 3X Shares

Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Top Performing Leveraged/Inverse ETFs: 09/11/2022

The biotech sector deflated, as most sectors did, in the first half of 2022. However, the sector is in the midst of a comeback as mergers and acquisitions rise, signaling increased activity.

Biotech Bounces in August as M&A Activity Increases

During July, LABU traded in a narrow range. In August, its uptrend has resumed. We expect that LABU's uptrend has a long way to go.

LABU Continues In Uptrend (Technical Analysis)

ProShares Ultra Nasdaq Biotechnology

ProShares UltraShort Oil & Gas

Direxion Daily Energy Bear 2X Shares

Top Performing Leveraged/Inverse ETFs: 08/07/2022

I believe small- and mid-cap biotech bottomed in May through June and has outperformed the broader market since then. Biotech continues to show strong relative outperformance versus the market and most sectors/industries.

LABU And The Biotechs Look Ready To Outperform (Technical Analysis)

The biotech sector has been rallying as of late, evidenced by the S&P 500 Biotechnology Index up close to 9% within the past month. Of course, as we've seen so far in 2022, rallies are difficult to sustain given the market uncertainty.

Biotech Sector Is Garnering Interest From Investors Again

ETFMG Prime 2x Daily Inverse Junior Silver Miners ETF

ProShares Ultra Semiconductors

Top Performing Leveraged/Inverse ETFs: 07/10/2022

Starting with September 2021, LABU had a record sequence of nine consecutive months with negative returns. During the biotech downtrend from September 2021 to April 2022, LABD has returned 207%.

Leveraged Biotech ETFs: Buy LABU, Sell LABD

Direxion Daily Healthcare Bull 3x Shares

Top Performing Leveraged/Inverse ETFs: 06/26/2022

U.S. stocks saw a massive jump on the final trading session of last week, making the week successful one.

S&P 500's Second-Best Week in 2022: Best Leveraged ETFs

Since my last coverage in the previous quarter, LABU has been on a free fall for the past 12 weeks and also recorded a huge loss over the past 6. 3X funds like LABU have the highest expense ratio and  extreme levels of volatility.

LABU: This 3X Leveraged Bull ETF Fails To Raise Any Optimism

Direxion Daily MSCI Mexico Bull 3X Shares

Direxion Daily Utilities Bull 3X Shares

Direxion Daily Real Estate Bull 3x Shares

Direxion Daily Financial Bear 3X Shares

Direxion Daily 20+ Year Treasury Bull 3X Shares

ProShares Ultra Real Estate

Top Performing Leveraged/Inverse ETFs: 04/03/2022

Extremely poor, mostly high negative return since LABU's inception.

LABU: A 3X Leveraged ETF Best Avoided

Direxion Daily Small Cap Bull 3x Shares

Here are 3 stocks to buy on dips from scary geopolitical risks from Russia. These leveraged ETFs move extremely fast so bring your Dramamine.

3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty

News for Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU)